Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for XNCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 456.45M
March 31, 2026 444.95M
December 31, 2025 547.73M
September 30, 2025 471.04M
June 30, 2025 443.86M
March 31, 2025 469.57M
December 31, 2024 497.78M
September 30, 2024 542.98M
June 30, 2024 508.41M
March 31, 2024 535.94M
December 31, 2023 593.72M
September 30, 2023 494.53M
June 30, 2023 551.37M
March 31, 2023 588.02M
December 31, 2022 621.76M
September 30, 2022 600.24M
June 30, 2022 511.92M
March 31, 2022 389.76M
December 31, 2021 333.31M
September 30, 2021 288.20M
June 30, 2021 450.05M
March 31, 2021 551.98M
December 31, 2020 601.60M
September 30, 2020 551.16M
June 30, 2020 586.26M
Date Value
March 31, 2020 573.90M
December 31, 2019 527.08M
September 30, 2019 546.48M
June 30, 2019 505.17M
March 31, 2019 340.36M
December 31, 2018 292.06M
September 30, 2018 271.60M
June 30, 2018 255.41M
March 31, 2018 462.41M
December 31, 2017 222.43M
September 30, 2017 209.95M
June 30, 2017 188.49M
March 31, 2017 154.79M
December 31, 2016 128.74M
September 30, 2016 104.30M
June 30, 2016 91.10M
March 31, 2016 92.36M
December 31, 2015 96.43M
September 30, 2015 127.94M
June 30, 2015 67.88M
March 31, 2015 144.24M
December 31, 2014 54.65M
September 30, 2014 60.92M
June 30, 2014 66.22M
March 31, 2014 72.54M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
UroGen Pharma Ltd. 109.30M
MeiraGTx Holdings Plc 143.17M
Regeneron Pharmaceuticals, Inc. 8.005B
Ironwood Pharmaceuticals, Inc. 79.13M
MacroGenics, Inc. 173.30M